This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Myrbetriq ER 50 mg tablets, a medication used to treat overactive bladder. The contract has a ceiling value of $14,356.96 and a period of performance through April 16, 2025. It is a firm-fixed-price contract, with no set-aside designation, indicating open competition....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the provision of Myrbetriq ER 50 mg tablets, a medication used for the treatment of overactive bladder. The contract has a firm fixed-price, $34,152.51 ceiling value, and an ultimate completion date of February 21, 2024. This contract award is not associated with a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Myrbetriq ER 25 mg tablets, a medication used to treat overactive bladder. The contract has a firm fixed price and a ceiling value of $8,761.71. It was awarded on April 16, 2025, with an ultimate completion date of April 17, 2025. The contract is not set aside and is an open competition. AmerisourceBergen Drug Corp...
This is a delivery order contract awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) Troop Support Medical, a major defense agency. The contract is for the supply of Myrbetriq ER (mirabegron) 50 mg tablets, a medication used to treat overactive bladder. The contract has a ceiling value of $10,764.01 and runs through August 6, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Myrbetriq ER 50 mg tablets, a medication used to treat overactive bladder. The contract has a firm fixed price, non-set-aside designation, and a ceiling value of $12,154.60. It is a part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen Drug Corp with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Myrbetriq ER 50 mg tablets, a pharmaceutical product used for the treatment of overactive bladder. The contract has a ceiling value of $4,816.17 and runs until February 10, 2025. This contract is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds...
This is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Myrbetriq ER 25 mg tablets, a medication used to treat overactive bladder. The contract has a ceiling value of $12,557.35 and a performance period ending on April 23, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Myrbetriq ER 50 mg tablets, a medication used to treat overactive bladder. The contract has a firm fixed price of $8,598.18 and a completion date of August 11, 2023. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Myrbetriq ER 50 mg tablets, a medication used to treat overactive bladder. The contract has a ceiling value of $3,572.77 and a period of performance through April 8, 2025. This is a firm fixed-price delivery order contract, and there is no set-aside designation. AmerisourceBergen holds...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a major pharmaceutical distribution company. The contract is for the delivery of Myrbetriq ER 50 mg tablets, a branded medication used to treat overactive bladder. The firm fixed price contract has a ceiling value of $12,257.36 and a period of performance through February 10, 2022. Amerisourcebergen Drug Corp has an...